On June 5, 2017, the U.S. Drug Enforcement Administration (DEA) conducted a formal inspection of the study site at Emory University for our upcoming Phase 1 study on the effect of MDMA on startle testing in healthy volunteers. Principal Investigator Barbara Rothbaum, Ph.D., a leading PTSD researcher, will conduct the MAPS-sponsored study at Emory University in Atlanta, Georgia. The study will begin after DEA approval. This study will be followed by one exploring the combination of MDMA with Prolonged Exposure in PTSD patients. Learn more…